Efficacy Of Trimrox On Body Recomposition And Weight Management (TRCAP21)

NCT05283525 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-03-17

No results posted yet for this study

Summary

Protocol Number: VNI/121/TrimRox:

A unique stimulant- and sugar-free TRCAP21 Prodosomed® nutraceutical formulation, TrimROXTM, has been developed in a cGMP and NSF-certified manufacturing facility that is CFR-111 A compliant as well as having a BRC A rating, ensuring compliance with the Global Food Safety Initiative (GFSI). The investigators developed a stimulant- and sugar-free TRCAP21 Prodosomed® nutraceutical technology that effectively addresses directly and indirectly all the contributing factors. The investigators will conduct a 90-day study investigation in 100 study participants to assess the efficacy of TRCAP21 on diverse anthropometric aspects including chest, upper arms, waist/belly, hips and thighs, body weight, height, body mass index (BMI), and overall health and well-being.

Conditions

  • Body Weight Changes

Interventions

DIETARY_SUPPLEMENT

Anthropometric Measurement of the Chest, Upper Arm/Bicep, Hips, Thighs and Waist/ Belly in Inches

0 - 90 Days of Treatment

DIETARY_SUPPLEMENT

Oxygen Saturation

0 - 90 Days of Treatment

DIETARY_SUPPLEMENT

Total Blood Chemistry

0 and 90 Days of Treatment

DIETARY_SUPPLEMENT

Adverse Event Monitoring

Adverse Event Monitoring Throughout the Study

DIETARY_SUPPLEMENT

Body Weight Monitoring

0 - 90 Days of Treatment

DIETARY_SUPPLEMENT

Physical well-being including mood, energy, satiety level. sugar cravings, sleep, and overall health

0 - 90 Days of Treatment

Sponsors & Collaborators

  • Victory Nutrition International, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-23
Primary Completion
2023-02-28
Completion
2024-01-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05283525 on ClinicalTrials.gov